Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies.
Sawada A, Shimizu M, Isaka K, Higuchi K, Mayumi A, Yoshimoto Y, Kikuchi H, Kondo O, Koyama-Sato M, Yasui M, Kawa K, Inoue M. Sawada A, et al. Among authors: mayumi a. Pediatr Hematol Oncol. 2014 Nov;31(8):754-64. doi: 10.3109/08880018.2014.961214. Epub 2014 Oct 17. Pediatr Hematol Oncol. 2014. PMID: 25325678 Clinical Trial.
HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning with very low-dose antithymocyte globulin for relapsed/refractory acute leukemia in pediatric patients: a single-institution retrospective analysis.
Higuchi K, Sawada A, Kondo O, Okada Y, Tsujimoto H, Ioi A, Mayumi A, Shimizu M, Sato M, Goto K, Inoue S, Yasui M, Inoue M. Higuchi K, et al. Among authors: mayumi a. Int J Hematol. 2022 Mar;115(3):406-413. doi: 10.1007/s12185-021-03270-z. Epub 2022 Jan 14. Int J Hematol. 2022. PMID: 35028882
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.
Ikegame K, Kaida K, Fukunaga K, Osugi Y, Yoshihara K, Yoshihara S, Ishii S, Fujino S, Yamashita T, Mayumi A, Maruyama S, Teramoto M, Inoue T, Okada M, Tamaki H, Ogawa H, Fujimori Y. Ikegame K, et al. Among authors: mayumi a. Bone Marrow Transplant. 2021 Jan;56(1):70-83. doi: 10.1038/s41409-020-0980-8. Epub 2020 Jun 20. Bone Marrow Transplant. 2021. PMID: 32564055 Clinical Trial.
Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation.
Teramoto M, Maruyama S, Tamaki H, Kaida K, Mayumi A, Fukunaga K, Inoue T, Yoshihara K, Yoshihara S, Ikegame K, Okada M, Osugi Y, Ogawa H, Higasa S, Morita K, Matsumoto K, Kijima T. Teramoto M, et al. Among authors: mayumi a. Int J Hematol. 2022 Aug;116(2):248-257. doi: 10.1007/s12185-022-03342-8. Epub 2022 May 6. Int J Hematol. 2022. PMID: 35522381
Toxoplasmic Encephalitis Followed by Primary EBV-Associated Post-Transplant Lymphoproliferative Disorder of the Central Nervous System in a Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.
Mayumi A, Yamashita T, Matsuda I, Hikosaka K, Fujino S, Norose K, Kato Y, Hirota S, Nakajima T, Ogawa H, Ikegame K. Mayumi A, et al. Transplant Proc. 2020 Nov;52(9):2858-2860. doi: 10.1016/j.transproceed.2020.08.002. Epub 2020 Aug 29. Transplant Proc. 2020. PMID: 32873410
15 results